Cargando…

In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines

Neuroblastoma is the most frequent malignant extracranial solid tumor of infancy. The overall objective of this work consists of determining the presence of alterations in the p53/MDM2/p14ARF signaling pathway in neuroblastoma cell lines and deciphering their possible relationship with resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco-Luquin, Idoia, Lázcoz, Paula, Celay, Jon, Castresana, Javier S., Encío, Ignacio J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624165/ https://www.ncbi.nlm.nih.gov/pubmed/34832966 http://dx.doi.org/10.3390/ph14111184

Ejemplares similares

Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment
por: Celay, Jon, et al.
Publicado: (2013)

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
por: Lázcoz, Paula, et al.
Publicado: (2006)

Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR
por: Lorente, Aiala, et al.
Publicado: (2008)

Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas
por: Muñoz, Jorge, et al.
Publicado: (2012)

High-SETD8 inactivates p53 in neuroblastoma
por: Veschi, Veronica, et al.
Publicado: (2017)

Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma
por: Chen, Lindi, et al.
Publicado: (2015)

Expression of C-terminal deleted p53 isoforms in neuroblastoma
por: Goldschneider, David, et al.
Publicado: (2006)

Combining selinexor with alisertib to target the p53 pathway in neuroblastoma
por: Nguyen, Rosa, et al.
Publicado: (2022)

Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
por: Michaelis, M, et al.
Publicado: (2012)

The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas
por: Miyazaki, Makoto, et al.
Publicado: (2018)

Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cells
por: Meng, Jinhong, et al.
Publicado: (2020)

The Participation of Microglia in Neurogenesis: A Review
por: Pérez-Rodríguez, Diego R., et al.
Publicado: (2021)

TP53BP2 decreases cell proliferation and induces autophagy in neuroblastoma cell lines
por: Pang, Yi, et al.
Publicado: (2019)

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
por: Rihani, Ali, et al.
Publicado: (2015)

Occurrence of Neuroblastoma among TP53 p.R337H Carriers
por: Seidinger, Ana Luiza, et al.
Publicado: (2015)

p53-Mediated Radiosensitization of (177)Lu-DOTATATE in Neuroblastoma Tumor Spheroids
por: Lundsten, Sara, et al.
Publicado: (2021)

Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment
por: Almeida, Joana, et al.
Publicado: (2022)

p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor
por: Levesque, Aime A., et al.
Publicado: (2022)

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Aluminium Induced Endoplasmic Reticulum Stress Mediated Cell Death in SH-SY5Y Neuroblastoma Cell Line Is Independent of p53
por: Mustafa Rizvi, Syed Husain, et al.
Publicado: (2014)

S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines
por: IKEGAKI, NAOHIKO, et al.
Publicado: (2013)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
por: Acosta, Sandra, et al.
Publicado: (2009)

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma
por: Chen, Tingting, et al.
Publicado: (2022)

Field exposure to 50 Hz significantly affects wild-type and unfolded p53 expression in NB69 neuroblastoma cells
por: Martínez, María Antonia, et al.
Publicado: (2022)

USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis
por: Fan, Y-H, et al.
Publicado: (2013)

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
por: Gamble, Laura D., et al.
Publicado: (2011)

A p53 Drug Response Signature Identifies Prognostic Genes in High-Risk Neuroblastoma
por: Barbieri, Eveline, et al.
Publicado: (2013)

NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis
por: Shi, Y, et al.
Publicado: (2015)

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth
por: Ménard, Marie, et al.
Publicado: (2018)

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
por: Akter, Jesmin, et al.
Publicado: (2021)

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
por: Van Goethem, Alan, et al.
Publicado: (2023)

Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells
por: Rodríguez-Losada, Noela, et al.
Publicado: (2020)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

Management of neuroblastoma: a study of first- and second-line chemotherapy responses, a single institution experience
por: Habib, Emmad E., et al.
Publicado: (2012)

Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation.
por: Abemayor, E, et al.
Publicado: (1989)

In Vitro Transfection of Up-Regulated Genes Identified in Favorable-Outcome Neuroblastoma into Cell Lines
por: Hiyama, Yoko, et al.
Publicado: (2022)

Epigenomic profiling of neuroblastoma cell lines
por: Upton, Kristen, et al.
Publicado: (2020)

Oridonin induces Mdm2‐p60 to promote p53‐mediated apoptosis and cell cycle arrest in neuroblastoma
por: Zhu, Han‐Qing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_65evs157r0mh2g28l51q8hjr1o